Latest return on equity
enGene Therapeutics Return on equity
Direct answer
enGene Therapeutics's return on equity is -60.5%.
The verified market snapshot reports -60.5%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free enGene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -60.5%
Explore related company data
View enGene Therapeutics's market capitalizationView enGene Therapeutics's price-to-book ratioView enGene Therapeutics's dividend yieldView enGene Therapeutics's 52-week price rangeView enGene Therapeutics's profit marginView enGene Therapeutics's debt-to-equity ratioView all enGene Therapeutics key metricsReturn to enGene Therapeutics profile